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Abstract. Individual isoforms of the protein kinase C 
(PKC) family of kinases may have assumed distinct re- 
sponsibilities for the control of complex and diverse 
cellular functions. In this study, we show that an iso- 
form specific interaction between PKCe and filamen- 
tous actin may serve as a necessary prelude to the en- 
hancement of glutamate exocytosis from nerve 
terminals. Using a combination of cosedimentation, 
overlay, and direct binding assays, we demonstrate that 
filamentous actin is a principal anchoring protein for 
PKCe within intact nerve endings. The unusual stability 
and direct nature of this physical interaction indicate 
that actin filaments represent a new class of PKC-bind- 
ing protein. The binding of PKCe to actin required that 
the kinase be activated, presumably to expose a cryptic 
binding site that we have identified and shown to be lo- 
cated between the first and second cysteine-rich regions 
within the regulatory domain of only this individual iso- 
form of PKC. Arachidonic acid (AA) synergistically  in- 
teracted with diacylglycerol  to stimulate actin binding 
to PKCe. Once established, this protein-protein inter- 
action securely anchored PKCe to the cytoskeletal ma- 
trix while also serving as a chaperone that maintained 
the kinase in a catalytically active conformation. Thus, 
actin appears to be a bifunctional anchoring protein 
that is specific for the PKCe isoform. The assembly of 
this isoform-specific signaling complex appears to play 
a primary role in the PKC-dependent facilitation of 
glutamate exocytosis. 
VOLUTION has conserved a fundamental mechanism 
that  ensures  the  sorting and  fusion of secretory 
vesicles upon their delivery to appropriate destina- 
tions along the secretory pathway. In many eukaryotes, 
however, alternative pathways have emerged in which ves- 
icle delivery and fusion have become rigorously regulated 
events that are capable of manifesting use-dependent vari- 
ations in the probability of their occurrence.  Glutamate 
exocytosis is a particularly striking example of a secretory 
event that, in presynaptic nerve terminals, has acquired a 
highly evolved mechanism for regulating the efficiency of 
excitatory synaptic transmission. Moreover, it has been es- 
tablished  that  use-dependent  changes  in  the  reliability 
(Stevens and Wang, 1994) and extent (Schulz et al., 1994) 
of glutamate exocytosis directly participate in certain forms 
of synaptic plasticity. 
Studies  from many laboratories suggest  that  a  condi- 
tional  relationship may exist  between  the  efficiency  of 
glutamate release and the activity of presynaptic protein 
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kinase C (PKC). 1  These studies have shown that the Ca  2+- 
dependent release of glutamate is significantly enhanced 
in the presence of phorbol esters, which activate most iso- 
forms of PKC, and that this effect can be blocked by inhib- 
itors of serine/threonine kinase activity (Yamamoto et al., 
1987; Madison et al., 1991; Huang et al., 1992). Confirma- 
tion of these results in preparations of isolated nerve end- 
ings  (synaptosomes) established a  presynaptic locus  for 
the PKC-dependent enhancement of sustained glutamate 
release and provided a simple system in which to identify 
the molecular components of the PKC signaling pathway 
that are capable of facilitating synaptic vesicle recruitment 
during bouts of intense synaptic activity  (Terrian et al., 
1993). The PKC family includes  at least 11  different iso- 
forms that possess  different requirements for activation 
and are widely believed to have assumed distinctive cellu- 
lar responsibilities  (for reviews see Nishizuka,  1992; Hug 
1.  Abbreviations  used  in  this  paper:  AA,  arachidonic  acid;  GAP-43, 
growth-associated  protein;  GS1-406,  truncated  recombinant  gelsolin; 
OAG, oleyl-acetyl-glycerol; P3, hippocampal mossy fiber-enriched synap- 
tosomal fraction; PDBu, phorbol 12,13-dibutyrate; PS, phosphatidylserine; 
PKC, protein kinase C; RACK, receptors for activated C kinase; TX100, 
Triton X-100. 
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on this growing family of protein kinases has concentrated 
on the individual functions of these isoforms. The PKC 
gene family is  divided into three subfamilies;  the  Ca  2+- 
dependent  or  conventional  (PKCa,  [3i, 13n, and  ",/), the 
Ca2+-independent or novel (PKCS, e, TI, O, and  ~), and 
phorbol ester-insensitive or atypical subfamilies  (PKC 
and ~/h). The synaptosomal preparation used in our previ- 
ous studies has been shown to contain at least five of the 
known isoforms of PKC (PKCct, [3, % e, and ~) and eight 
unidentified endogenous substrates  for this kinase  (Ter- 
rian et al., 1993; Terrian, 1995; Terrian and Ways, 1995). 
The coexistence of various PKC isoforms within an assort- 
ment of isolated nerve endings and their relatively minor 
differences in substrate specificity (Hug and Sarre, 1993; 
Dekker  and  Parker,  1994)  raises  the  question  of how 
heterogeneous  and  isoform-specific functions  might  be 
achieved within the same presynaptic terminal. 
One mechanism that is likely to contribute to the opera- 
tional diversity of PKC isoforms involves the differential 
colocalization of an activated PKC isoform with its endog- 
enous protein substrates  (for review see  Mochly-Rosen, 
1995). Indeed, although phorbol esters activate the major- 
ity of PKC isoforms, many of the isoforms which are present 
within a given cell translocate to different subcellular do- 
mains (Kiley et al., 1992; Disatnik et at.,  1994; Staudinger 
et a1., 1995).  Cell specific patterns of redistribution may 
also be observed for an individual PKC isoform, depend- 
ing on the complement of isoform specific PKC-binding 
proteins that are expressed by the cell. These intracellular 
PKC-binding proteins, sometimes referred to as  "recep- 
tors for activated  C  kinase"  (RACKs;  Mochly-Rosen et 
al., 1991) or as proteins that interact with C-kinase (PICKs; 
Staudinger et al.,  1995), are believed to determine the to- 
pogenic fate of the PKC isoforms by differentially anchor- 
ing the  PKCs to specific cellular compartments.  Several 
PKC-binding proteins have now been cloned and shown to 
preferentially  interact  with  certain  isoforms  of  PKC 
(Chapline  et  al.,  1993;  Ron  et  al.,  1994).  However, no 
PKC-binding protein known to us has been shown to be 
specifically paired  with  an  individual  isoform  of  PKC. 
Such absolute targeting specificity would require that the 
anchoring protein contain a  binding site that is uniquely 
matched to an isoform-specific localization signal. 
In the present study, we have examined the potential in- 
volvement of individual PKC isoforms in the enhancement 
of sustained glutamate exocytosis, the pattern of their sub- 
cellular redistribution, the  determinants  of isoform spe- 
cific targeting within presynaptic terminals, and the condi- 
tions required for their constitutive activation. The results 
revealed that  at least one requirement for the  enhance- 
ment of sustained glutamate exocytosis may be the posi- 
tioning of activated PKCe within the cytoskeletal matrix of 
presynaptic terminals. Four independent lines of evidence 
indicated that the PKCe isoform was selectively anchored 
to this complex aggregate of insoluble proteins through an 
unusually  secure  and  direct  protein-protein  interaction 
with filamentous actin. Using purified actin and recombi- 
nant PKCe, it was confirmed that complementary domains 
within  these  proteins physically interacted with  one an- 
other through the formation of a salt-bridge that was sta- 
ble at physiological ionic strength.  In addition, an actin- 
binding motif was identified in the regulatory domain of 
PKCe that appeared to be conformationally hidden when 
the kinase was inactive and that is not conserved in any 
other known members of the PKC family. These observa- 
tions support the notion that PKC¢ contains an actin-bind- 
ing sequence that assigns a  distinct responsibility to this 
individual kinase in mediating the PKC-dependent replen- 
ishment of synaptic vesicles during repetitive bouts of pre- 
synaptic depolarization. 
Materials and Methods 
In Vivo Destruction of Dentate Granule Cells 
Male Sprague-Dawley rats were anesthetized and positioned in a  Kopf 
stereotaxic apparatus. Two unilateral intradentate injections of colchicine 
(3.5 p~g) were delivered, using the coordinates described previously (Con- 
ner-Kerr et al., 1993). Contralateral sham injections were also delivered to 
each animal. After a postinjection period of 10 d, animals were sacrificed, 
hippocampi were removed, and synaptosomes were prepared (see below) 
using either the sham- or colchicine-injected hippocampi as starting tissue. 
Colchicine selectively destroyed the rat, but not guinea pig, dentate gran- 
ule cell-mossy fiber pathway under these conditions (Conner-Kerr et al., 
1993). 
Synaptosomal Preparation 
Male Hartley guinea pigs were used in all experiments that did not require 
the use of colchicine-induced lesions. Animals were decapitated, the hip- 
pocampi removed and manually disrupted in a 0.3 M sucrose medium con- 
taining 1 mM MgSO  4 and 15 mM sodium N-tris (hydroxymethyl) methyl- 
2-aminoethane-sulfonic acid (pH 7.4)  at 0-5°C, using custom-machined 
Dounce type homogenizers (Terrian et al., 1988). The differential centrif- 
ugation procedures used to prepare  hippocampal mossy fiber-enriched 
fractions (P3) have been described in detail (Tertian et al., 1988). An iden- 
tical protocol was used to isolate P3 fractions from sham- or colchicine- 
injected rat hippocampi. Synaptosomal pellets were resuspended in an oxy- 
genated, Ca2+-free, Krebs-bicarbonate medium (Tertian, 1995). 
Phorbol Ester Preincubation Conditions 
Synaptosomes were incubated for 5 min at 30°C before introducing CaCl2 
(1.4 mM) to the medium and incubating for an additional 15 min. Aliquots 
of the synaptosomal suspension were then transferred to separate tubes 
and incubated at 30°C for 10 min in the presence of the PKC activator, 413- 
phorbol 12,13-dibutyrate (413-PDBu;  1 ~M), or an equimolar concentra- 
tion of the inactive phorbol ester, 4ct-PDBu. Where specified, intact syn- 
aptosomes were exposed to 1 I~M cytochalasin D, 1 IxM staurosporine, or 
100 p~M sphingosine 20 min before the introduction of phorbol esters. 
Superfusion Procedures 
Aliquots of the synaptosomal suspension were layered onto parallel su- 
perfusion columns (Terrian,  1995)  and superfused (0.5  ml/min) at room 
temperature with an oxygenated Krebs-bicarbonate medium containing 
1.4 mM CaCI2.  The relatively hydrophilic phorbol ester, PDBu, is com- 
pletely washed out of intact synaptosomes within a  28-min exposure to 
these superfusion conditions (Tertian et al., 1993).  Beginning at 27 min, 
four sequential 5-min superfusate fractions were collected and prepared 
for  fluorometric  assay of  glutamate  by  measuring the  production  of 
NADH by glutamic acid dehydrogenase (Terrian et al., 1988).  Glutamate 
release was evoked by the introduction of 35 mM KCI to the superfusion 
medium, in equimolar substitution for NaC1 (Tertian and Ways, 1995). 
Cellular Fractionation 
Synaptosomes were disrupted by sonication in 20 mM Tris-HCl (pH 7.4) 
containing 10 mM EDTA, 2  mM EGTA, 100  mM 13-glycerophosphate, 
0.05  mg/ml phcnylmethylsulfonyl fluoride, 0.1  mg/ml aprotinin, 1 mg/ml 
leupeptin, 2 ~M pepstatin, and 0.1 mg/ml ovalbumin. Cytosolic fractions 
were obtained by centrifugation (78,000 g for 20 min at 4°C). Using a re- 
combinant PKCe standard, it was determined that the resulting superna- 
tant contained a  weight ratio of 7 ng PKCe/1  Ixg cytosolic protein. The 
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(vol/vol) Triton X-100 (TX100) solution at 4°C for 20 min, unless specified 
otherwise. The TX100-soluble and -insoluble fractions were  then sepa- 
rated by sedimentation (20 min at 78,000 g).  In some experiments, the 
TX100-insoluble material was reextracted  using a  variety of additional 
solubilization protocols for 30 min at 4°C (see Table I). All TX100-insolu- 
ble fractions were finally resuspended in a  cytoskeletal buffer that con- 
sisted of 125 mM Tris-HC1 (pH 6.8), 1.25% SDS, 3 mM EDTA, 0.25 M su- 
crose, 10% glycerol, 1% 2-mercaptoethanol, and protease inhibitors (see 
above). 
Cosedimentation Assays 
The CaZ+-independent, in vitro, binding of native PKCs to the 1% TX100- 
insoluble fraction was analyzed using a modification of the cosedimenta- 
tion assay described by Mochly-Rosen et al. (1991). In brief, 100 ~g of 1% 
TX100-insoluble synaptosomal protein was resuspended in 50  ~1 of 20 
mM Tris-HC1 (pH 7.4) containing 10 mM EDTA, 2 mM EGTA, 100 mM 
[3-glycerophosphate, and 0.05 mg/ml PMSF, and preincubated for 30 min 
at  30°C.  Where  indicated,  the  1%  TX100-insoluble  fraction  was  pre- 
treated with trypsin (Mochly-Rosen et al., 1991)  or 25 p.g of recombinant 
gelsolin GS1-406 (Sun et al., 1994).  Sonicated phosphatidylserine (PS) li- 
posomes (20 p~g/ml) and CaCI  2 (1  raM) were also added to the reaction 
medium, where specified. Native synaptosomal cytosol (150 ~g protein) 
was then introduced, in the presence of the indicated amount of either 4ct- 
PDBu  or  4[3-PDBu,  to  a  final  volume of  120  i~l  incubation  medium. 
TX100-insoluble aggregates were sedimented and subjected to immuno- 
blot analysis as previously described (Tertian et al., 1991),  using antipep- 
tide antisera specific for the a, [3  n, ~, and [ isoforms of PKC. These anti- 
sera  recognize  proteins  of  the  predicted  molecular  mass  for  their 
respective  isoforms. The  specificity of the  detected  proteins  was  con- 
firmed by the ability of the immumzing peptide  to abolish detection of 
these bands (Ways et al.,  1991; Tertian et al.,  1993).  Antibody-reactive 
bands were visualized with either peroxidase-labeled secondary antibod- 
ies  and  enhanced chemilt~minescence or  i25I-protein  A.  Den~ltometric 
analysis of the autoradlograms was performed to quantify changes in the 
relative content of PKC. 
Actin-binding Assays 
Varying amounts of purified rabbit skeletal muscle actin were  preincu- 
bated for 30 min at room temperature, in 150 tJ.l of 4 mM Tris-HCl (pH 
7.5) containing 10 ~tM CaCl:, 30 mM KC1, 120 mM potassium proponate, 
1 mM MgC12, 150 ~M ATP, and 100 p.M ZnC12, before the addition of 50 
p.g synaptosomal cytosol (350 ng PKCe). The volume of the incubation 
mixture was adjusted to 220 ~l and samples were incubated for 30 min at 
30°C in the presence of either 1 ixM 4a-PDBu or 4[~-PDBu. Where indi- 
cated, varying amounts of synthetic peptides (LKKQET, PKCcqg_31,  or an- 
nexm I338.345) were added to the incubation medium at the same time as 
PDBu. Mixtures of purified actin and native cytosol were also incubated 
in  the presence of 1  p~M oleyl-acetyl-glycerol (OAG),  with  or without 
varying concentrations of arachidonic acid (AA). Filamentous actin was 
sedimented (78,000 g for 30 min at 4°C) and resuspended in cytoskeletal 
buffer before SDS-PAGE and immunoblot analysis. In an addxtional se- 
ries of experiments, purified and denatured human recombinant PKCct, 8, 
and ~ (100 ng of each) were individually colncubated with purified actin, 
in the absence of 4~-PDBu and in the absence or presence of the synthetic 
hexapeptide, LKKQET (80 ~M). The volume was adjusted to 220 p.l and 
samples were incubated for 30 min at room temperature before sediment- 
ing the filamentous actm, as above, and resuspending the pellets in cyto- 
skeletal buffer for immunoblot analysis. The final actin concentration was 
5  ~M in each assay, the minimum required for reproducible  sedimenta- 
tion of actin pellets. 
Overlay Assays 
Denatured, 1% TX100-insoluble, synaptosomal proteins that are capable 
of binding to native PKC under in vitro conditions were analyzed using a 
modification of the overlay assay described by Jaken and colleagues (Liao 
et al., 1994).  TX100-insoluble protein (150 Ixg) was denatured and sepa- 
rated by SDS-PAGE  and transferred to  nitrocellulose membranes that 
were incubated for 3 h  at 4°C with a Tris-buffered saline (TBS) that con- 
tained 5% milk powder. The TBS consisted of 10 mM Tris-HC1 (pH 7.4) 
and 150 mM NaCI. Nitrocellulose filter-bound proteins were then washed 
twice with TBS and incubated for 1 h  at room temperature in TBS con- 
taining 10 ~g/ml cytosolic protein, 10 mg/ml bovine serum albumin, 1 mM 
EGTA, 10 p,g/ml leupeptin, 10 ixg/ml aprotonin, and I  ~M 4[3-PDBu. Af- 
ter two more washes with phosphate-buffered saline, the membranes  were 
probed using either anti-PKCa, e, 4, or anti-[3 actin antisera. 
In Vitro Protein Phosphorylation 
Synaptosomal 1% TX100-insoluble protein (150 I~g) was resuspended in 
200 ~l of Tris-HCl (pH 7.4) that contained native cytosolic protein (80 
~g), 0.1 mM EGTA, and i  I~M 4u-PDBu or 4~-PDBu. After a 5-min incu- 
bation  at  room  temperature,  insoluble  aggregates  were  sedimented 
(13,500  g  for 5  min). Where specified, these pellets were  washed three 
times with 200 p,l of 20 mM Tris-HC1 (pH 7.4). The final pellets were all 
resuspended in  185  i~l of 20 mM Tris-HCl (pH 7.4) containing 0.1  mM 
EGTA. The assay of in vitro phosphotransferase activity was initiated by 
adding 15 ixl of 20 mM Tris-HCl containing 180 mM MgCl2,  12 IxM ATP, 
and [3,-32p]ATP (0.26 mCi/ml). Samples were incubated for 5 min at 30°C 
and sedimented as before. Pellets were washed twice with 200 p,1 of 20 
mM Tris-HC1  (pH  7.4)  and  resuspended in  cytoskeletal  buffer before 
SDS-PAGE using 5-15 % linear gradient gels and autoradiographic analysis. 
Miscellaneous 
Treatment effects were evaluated by determining the significance of the 
difference between means using a paired Student's t test. SDS-PAGE us- 
ing 5-15% linear gradient gels was performed as described in the Hoefer 
Protein Electrophoresis Applications Guide. A  recombinant protein con- 
taining the amino-terminal half of gelsolin (GS1-406) was provided by Dr. 
Helen L. Yin, University of Texas Southwestern Medical Center (Dallas, 
TX). Antipeptide antisera against PKC~, [311, % 8, ¢, ~, "q, and O were pro- 
vided by Dr. D. Kirk Ways, East Carolina University School of Medicine 
(Greenville, NC). Purified actin was provided by Dr. Joseph M. Chalov- 
ich, East Carolina University School of Medicine. Purified human recom- 
binant PKC standards (ct, 8, and ~), were obtained from Oxford Biomedi- 
cal Research, Inc. Drtlgs were obtained from Sigma Chem. Co, (St. Louis, 
MO) and antibodies to 13-actin and growth-associated protein (GAP-43) 
were  obtained  from  Sigma Immunochemicals.. Anti-synaptoph~sin and 
anti-GAP-43 antibodies were obtained from Boehringer Mannheim Bio- 
chemica (St.  Louis, MO).  Synthetic peptides homologous to PKC¢223_228 
(LKKQET) and annexin I338-~5 (KILVALCG) were obtained from Bio- 
Synthesis,  Inc  (Lewisville,  TX).  The  pseudosubstrate  peptide,  PKC~19_ 
31,was obtained from LC Laboratories. 
Results 
Presynaptic Localization of PKCce, PKCe, and PKC~ 
We have taken advantage of the fact that colchicine selec- 
tively destroys the  rat dentate  granule cell -  mossy fiber 
pathway in vivo to identify proteins that are endogenous 
to hippocampal mossy fiber nerve endings.  Comparisons 
of the P3 fractions that were prepared from ipsilateral (le- 
sioned) and contralateral (sham-injected) hippocampi in- 
dicated  that  destruction  of the  mossy fibers reduced  the 
content of synaptophysin and  GAP-43; proteins that  are 
localized to the presynaptic terminals of all hippocampal 
neurons, by 93% and 63%, respectively (Fig. 1 A). In con- 
trast, the synaptosomal content of PKCI3u and ~ was unal- 
tered by colchicine (Fig.  1 B), indicating that mossy fiber 
nerve endings are unlikely to be the source of these PKC 
isoforms. The antipeptide antiserum against PKC'q did not 
detect any proteins of the predicted molecular mass in the 
P3 fraction. Although a ~116-kD immunoreactive protein 
that may represent a high molecular size isoform of PKC'q 
(Sublette et al.,  1993)  was observed, colchicine  appeared 
to increase rather than reduce the content of this unidenti- 
fied protein (Fig. 1 B). Colchicine-induced lesions also in- 
creased the content of PKC~ in the  P3 fraction. An anti- 
peptide antiserum against PKCO detected no proteins in 
Prekeris et al. Function  of an Actm-binding Site Umque to the PKC~ lsoform  79 Figure 1. Presynaptic localization of PKC isoforms by deletion analysis.  (A) Effects of selectively  removing mossy fiber nerve endings 
from hippocampal P3 subcellular fractions, using in vivo intradentate injections of colchicine,  on the relative content of two presynap- 
tic marker proteins, synaptophysin, and GAP-43. Hippocampal homogenates (H) are shown for reference. (B) Effects of colchicine- 
induced lesions on the recovery of various PKC isoforms (PKCa, [3ii, % 8, e, ~, and 0) in the rat hippocampal P3 subcellular fraction. 
"ND" means not detected. Equal amounts of protein were applied to the adjacent lanes of each gel shown in A and B, above. Repre- 
sentative blots are shown from two (PKCS) or three independent experiments and data are reported as the means ---SEM. 
either the P3 fraction or whole rat brain standard (data not 
shown). Only PKCet, ~, and ~ were significantly decreased 
as a result of this lesion (Fig. 1 B). These observations in- 
dicate that hippocampal mossy fiber nerve endings contain 
at least one representative from each of the three subfami- 
lies of PKC. 
4fl-PDBu Selectively  Promotes the Chelator-Stable 
Association of  PKCe with a TXlOO-resistant  Fraction 
That Is Maintained, In Situ, in the Absence of  4fl-PDBu 
Once established,  the 41~-PDBu-induced enhancement of 
glutamate exocytosis has been shown to become stabilized 
in intact synaptosomes and independent of phorbol esters, 
while remaining sensitive to PKC inhibitors (Terrian et al., 
1993; Terrian and Ways, 1995). In an attempt to determine 
whether this persistent facilitation of release was mediated 
by  either  reversible  or irreversible  hydrophobic interac- 
tions of PKC with membrane lipids (Bazzi and Nelsestuen, 
1988;  Kazanietz  et  al.,  1992),  translocation  assays  were 
performed  using  intact  synaptosomes.  Both  mechanisms 
are thought to contribute  to the constitutive activation of 
PKC.  The  principal  criteria  used  to  distinguish  between 
the  reversibly bound  and  "membrane-inserted"  forms of 
PKC are that, in the later case, the solubility of the enzyme 
is reduced when intact cells are treated with phorbol esters 
and that the association of PKC with the particulate frac- 
tion becomes independent of phorbol esters and resists ex- 
traction with EGTA, but not the detergent TX100 (Bazzi 
and Nelsestuen,  1988; Kazanietz et al.,  1992). In addition, 
the  enhancement  of glutamate  release  does not stabilize 
during an acute (1 min) exposure to 4~-PDBu, but persists 
when synaptosomes are pretreated for at least 10 min with 
413-PDBu, and then washed to remove this phorbol ester 
(Terrian  et  al.,  1993).  Using these  criteria,  synaptosomes 
were incubated for 45 min in the presence of either the in- 
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nous PKCc~, ~, and ~. Effects of 413-PDBu 
on the  subcellular  distribution  of PKC~ 
(A), PKC~ (B), and PKCe (C). Intact syn- 
aptosomes were incubated for 45 min and 
exposed to 1 IxM 41~-PDBu during the fi- 
nal period of incubation, for the time indi- 
cated.  Fractions  obtained  from  synapto- 
somes that were incubated for 45 min with 
the inactive phorbol  ester, 4c~-PDBu, are 
indicated  as  a 0-rain exposure.  Synapto- 
somes were then disrupted and separated 
into  cytosolic  and  particulate  fractions. 
Particulate fractions were extracted using 
0.1%  TX100 and  further  separated  into 
TX100-soluble and  TX100-resistant frac- 
tions.  Immunoblot  analysis was  used  to 
determine  the  effect of 413-PDBu on the 
solubility of PKCo~, ~, and ~. The stability 
of in situ PKC interactions were examined 
by removing 413-PDBu from intact synap- 
tosomes after  a  10-min exposure  (condi- 
tion  10W). Amounts  of protein  loaded 
into adjacent lanes of a given immunoblot 
were equivalent, but varied between frac- 
tions  and  isoforms. These  immunoblots 
are representative  of the results obtained 
in  three  independent  experiments  using 
0.1% TX100. At a final concentration  of 
1.0% TX100, the  same  results were  ob- 
tained in two additional experiments. 
active phorbol ester, 4a-PDBu, or 413-PDBu for 1, 10, or 
45 min and sonicated in the presence of a buffer that con- 
tained 2.4 mM EGTA. The solubility of PKC isoforms, fol- 
lowing their 413-PDBu-dependent redistribution, was ini- 
tially analyzed by extracting the particulate  protein with 
0.1% TX100, at a detergent to protein ratio of 5:1. Cytoso- 
lic, 0.1%  TX100-soluble, and 0.1%  TX100-resistant frac- 
tions  were  prepared  from  whole  synaptosomal  lysates. 
Where specified, PDBu was washed out of the intact syn- 
aptosomes before cellular fractionation. No effect of 413- 
PDBu on  the  distribution  of PKC~ was  detected  under 
these conditions (Fig. 2 A), indicating that the disruption 
of intact synaptosomes itself was not responsible for an ar- 
tifactual redistribution of the other, phorbol ester-respon- 
sive,  isoforms of PKC. Like PKC~, PKC~ also did not re- 
spond to 413-PDBu treatment (data not shown). The content 
of cytosolic PKCet, 13It, % and ~ decreased within 1 min of 
treatment with 4~3-PDBu. However, this decrease in PKCa, 
1311, and ~ solubility was completely reversed by removal of 
413-PDBu (Fig.  2 and data not shown). PKC~ was the sole 
member of the PKC family that could be localized to mossy 
fiber terminals (Fig. 1), maintained a persistent association 
with a particulate fraction in the absence of 413-PDBu in 
situ,  and resisted extraction with 2.4 mM EGTA in vitro 
(Fig.  2C).  In contrast to the membrane-inserted form of 
PKC, however, PKCe could not be extracted from the par- 
ticulate fraction using 0.1% TX100 (Fig. 2). 413-PDBu also 
significantly decreased  the  solubility  of PKCE  when ex- 
tractions  were  performed using  a  final  concentration of 
1%  TX100  (see  below).  These  observations  raised  the 
question  of  whether  or  not  the  4[3-PDBu-induced  de- 
crease in PKCe solubility resulted from a direct interaction 
between  the  kinase  and  membrane  bilayer  (Bazzi  and 
Nelsestuen, 1988) or the unexpected formation of a secure 
PKCe-cytoskeletal complex (Wolf and Sahyoun, 1986). 
Activated PKCe Becomes Insoluble Due to Saturable, 
Ionic, Protein-Protein Interactions That Are 
Independent of Calcium or Phosphatidylserine 
To determine  the nature  of PKCe binding that is  estab- 
lished under in situ conditions, intact synaptosomes were 
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Synaptosomal  1% TXl  OO-lnsoluble Matrix by 4fl-PDBu 
Insoluble protein*  Insoluble PKCe* 
Reextraction  (Total)  (4ct-PDBu) 
%  % 
None  44  174 
Octyl Glucoside  7  179 
(NH4)2SO  4  14  108 
NaCl  13  86 
pH 12  6  109 
Intact synaptosomes were treated with either 1 p.M 4ct-PDBu or 413-PDBu. Particulate 
fractions were obtained by centrifugation of synaptosomal lysates and initially ex- 
tracted with 1% TX100. All subsequent extractions from this 1% TX100-insoluble ag- 
gregate were performed at 4°C for 30 min. Octyl glucoside was used at a final concen- 
tration of 100 raM, (NI-I4)2SO4 at 250 raM, and NaCI at 3 M  concentrations. Alkali 
conditions were established using a 0.I-M Na2CO  3 buffer. 4ct-PDBu-treated synapto- 
somes were used as a paired control. 
* Insoluble protein is expressed as the percent of total synaptosomal protein that re- 
sisted extraction using 1% TXI00 alone (None) or with an additional reextraction by 
the methods specified. 
*  Insoluble PCKe represents the relative amount of PKCe that resisted extraction, us- 
ing the method specified. Aliquots from the same synaptosomal suspension were ex- 
posed to either 4ct- or 413-PDBu, extracted with 1% TX100, and reextracted in an iden- 
tical manner. Values are expressed as the percent of insoluble PKCe recovered in the 
paired 4a-PDBu control for each treatment condition. 
treated with either  1 IxM 4a-PDBu or 4[3-PDBu and the 
soluble and insoluble forms of PKCe were separated using 
1% TX100. The 1% TX100-insoluble material was then ei- 
ther analyzed directly or treated with a variety of alterna- 
tive solubilization buffers that contained both EDTA and 
EGTA. After treatment with 4a-PDBu, 44% of the total 
synaptosomal protein and ~10%  of the total endogenous 
PKCe was recovered in the  1% TX100-insoluble fraction 
(Table I). Thus, the majority of this enzyme appeared to 
be either  cytosolic or membrane associated  under  basal 
conditions.  413-PDBu  redistributed  an  additional  7%  of 
the total PKCe to the synaptic skeleton (173% of the cor- 
responding 4a-PDBu control, Table I), where this kinase 
now resisted solubilization by 1% TX100. To further chal- 
lenge the  ability of PKCe to resist solubilization by non- 
ionic detergents, samples of the TX100-insoluble material 
were reextracted using octyl glucoside. Octyl glucoside is a 
considerably  more  stringent  detergent  than  TX100  and 
displaces  even  detergent-resistant  glycosylphosphatidyl- 
inositol anchored  proteins from cell membranes (Brown 
and Rose, 1992). After reextracting the 1% TX100-insolu- 
ble material with 100 mM octyl glucoside, at a detergent to 
protein ratio of ~6:1, only 7%  of the total synaptosomal 
protein remained insoluble  (Table I). Western blots con- 
firmed  that  the  presynaptic  integral  membrane  protein, 
synaptophysin, was completely solubilized by this combi- 
nation  of detergent  extractions  (data  not  shown).  How- 
ever, no PKCe was recovered in the additional protein that 
had been solubilized by octyl glucoside (Table I). Thus, the 
4[3-PDBu-stabilized binding  of PKCe was clearly not  de- 
pendent on the direct interaction of this kinase with mem- 
brane lipids. In contrast, PKCe was completely displaced 
from  the  1%  TX100-insoluble  matrix  when  the  ionic 
strength (3 M NaC1) or alkalinity (pH 12) of the extraction 
buffer was increased (Table I), indicating that the in situ 
binding of PKCe may be mediated by electrostatic interac- 
tions between two or more proteins. The fact that Na2CO3 
buffers titrated to a  pH of 11 failed to interfere with the 
binding  of PKCe  suggested  that  these  ionic interactions 
were unusually stable (data not shown). 
Specific protein interactions are both saturable and con- 
centration dependent. After the coincubation of native cy- 
tosolic and 1% TX100-insoluble fractions in the presence 
of 4[3-PDBu, neither PKCa nor PKC~ cosedimented with 
the insoluble fraction (data not shown). As in the previous 
experiment, however, 413-PDBu significantly increased the 
association of PKCe with the 1% TX100-insoluble fraction 
(Fig. 3 A). PKCe binding was saturable and strictly depen- 
dent  on the  concentration  of soluble  PKCe that  was in- 
cluded in the incubation mixture (Fig.  3 B). To evaluate 
whether  PS  and  Ca  2÷  mediate  the  interaction  of PKCe 
with  an  unidentified  PS-binding  protein  (Wolf and  Sah- 
youn, 1986; Liao et al., 1994), sonicated PS liposomes and 
Figure 3. In vitro binding  of 
native,  cytosolic,  PKCe  to a 
1%  TX100  insoluble  aggre- 
gate  of  synaptosomal  pro- 
teins.  (A)  Conditions  re- 
quired for in vitro binding of 
PKCe. Cytosol  (150 p~g) and 
1%  TX100-insoluble  frac- 
tions  (100 Ixg) were coincu- 
bated in the absence (lanes 1 
and  2)  or  presence  of  the 
PKC activators, 1.4 mM CaC12 
(lanes 4, 6, and 7), 20 mg/ml 
PS (lanes 3, 4, 6, and 7) and 1 
p~M 4[3-PDBu (lanes 5, 6, and 
7). In lane 7, the 1% TX100- 
insoluble fraction was exposed 
to mild trypsinization  before 
the addition  of a  trypsin  in- 
hibitor  and  cytosol,  accord- 
ing to the method of Mochly-Rosen  et al. (1991). The same results were obtained in three independent experiments.  (B) Cytosolic 
PKC~ binding to the 1% TX100-insoluble fraction (50 ~g protein) at different concentrations  of cytosol. CaCI2, PS, and 413-PDBu were 
present at all points, in the concentrations  specified above. Data are the means ± SEM of the values obtained in three independent ex- 
periments. 
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Figure 4. Rate of dissociation for PKC~ binding in the absence of 
4[3-PDBu. PKCe binding to a 1% TX100 insoluble aggregate of 
synaptosomal proteins was established under in vitro conditions 
by coincubation with the native cytosol in the presence of 1 ~M 
413-PDBu. Three washes were performed to remove >90% of the 
bound 413-PDBu, this was confirmed using [3H]413-PDBu (inset). 
After incubation in the  absence of phorbol ester for the  time 
specified,  soluble and insoluble forms of PKCe were separated 
and immunoblot analyses were performed to determine the rela- 
tive  amount  of PKCe  that  remained  insoluble.  Data  are  the 
means  +  SEM  of the  values  from  three  independent  experi- 
ments. The turnover constant for bound PKCe was estimated by 
performing a curve fit on the mean values using Sigma Plot Scien- 
tific Graphing Software 2.0 (Jandel Scientific, Inc.). 
Ca  2+  were  added  to  the  in  vitro  cosedimentation  assay 
mixture.  As  shown  in  Fig.  3  A,  PKC~  binding  was  in- 
creased by 413-PDBu (lane 5) and abolished by pretreating 
the  1%  TX100-insoluble  fraction  with  trypsin  (lane  7). 
However, PS had no effect on the solubility of PKC~, in ei- 
ther the absence or presence of Ca  2+ (Fig. 3 A, lanes 3 and 
4), and the combination of PS and Ca  2÷ did not augment 
the 413-PDBu-induced binding of PKC~ (Fig. 3 A, lane 6). 
These data demonstrate that PKCe binds to the detergent- 
insoluble  fraction  via  direct  protein-protein  interactions 
that  are  not  dependent  on  the  formation  of a  "PS-Ca  2+ 
bridge" (Wolf and Sahyoun, 1986; Liao et al., 1994). 
It has previously been demonstrated that the 4ff-PDBu- 
dependent enhancement of glutamate exocytosis is depen- 
dent on the presence of an intact actin-based cytoskeleton 
(Terrian and Ways, 1995). Therefore, we tested the ability 
of 250 mM (NH4)2SO4 to solubilize  PKCe because of its 
reported  efficiency  in  extracting  the  filamentous,  actin- 
based, cytoskeleton from cellular lysates (Fey et al., 1984). 
(NH4)2SO  4 almost completely solubilized  the PKCe  (Ta- 
ble I). 
PKCe Remains Insoluble in the Absence of 4[3-PDBu 
and Native Cytosol 
To determine how tightly PKCe associates with the deter- 
gent-insoluble components of nerve endings, we examined 
the kinetics for the dissociation of this complex. Synapto- 
somal  cytosolic  and  1%  TXlOO-insoluble  fractions  were 
isolated  and then  reintroduced  to one  another,  under  in 
vitro conditions, in the presence of either 1 ixM 4ot-PDBu 
or 413-PDBu,  10 mM  EDTA,  and  2  mM  EGTA.  Essen- 
tially  all  of the  soluble  PDBu,  and  >90%  of the  bound 
PDBu, was then removed by washing the TX100-insoluble 
aggregate  three  times  (Fig.  4, inset). The  washed  pellets 
were next resuspended in a Tris buffer and aliquots of this 
suspension were removed at specified times to determine 
the amount of PKCe that remained bound to the TX100- 
insoluble fraction. Data were analyzed using the following 
equation: B(t  ) =  B 0 X  e(k/t); where B(t  ) was the amount of 
PKCe bound at any given time point, B0 was the maximal 
amount of bound PKCe, k was the turnover constant (l/r), 
and t was time. It was observed that, in the absence of 413- 
PDBu  and  in  the  presence  of chelators,  PKCe  and  the 
TX100-insoluble fraction remained tightly associated with 
one another  and exhibited  a  turnover constant of 0.0134 
(T =  75 min; Fig. 4). 
PKCe Remains Catalytically Active within the 
Presynaptic Cytoskeletal Matrix after the Removal of 
Phorbol Ester 
Phosphotransferase  activity is  not  required  for PKC~  to 
bind the detergent-insoluble  proteins.  Indeed, all in vitro 
cosedimentation assays were performed in the absence of 
ATP and under conditions which do not support this activ- 
ity. Thus, an alternative  mechanism must account for the 
ability of 413-PDBu to stabilize the repositioning of PKCe. 
It is well established  that when phorbol esters bind to the 
cysteine-rich regions of PKCs the cryptic pseudosubstrate 
and substrate-binding  domains  of these  enzymes dissoci- 
ate  and become exposed  (for review see Hug and  Sarre, 
1993).  This  observation  raised  the  possibility  that  PKCe 
could only interact with anchoring proteins when the en- 
zyme assumed an active conformation. An important func- 
tional consequence  of such a  requirement  would be that 
PKCe remained constitutively active while it was anchored 
to native PKCe-binding proteins.  The fact that PKC~ was 
the only endogenous isoform that bound to the detergent- 
Figure 5. In vitro phosphory- 
lation of native TX100-insol- 
uble  proteins  by  bound 
PKCe. Soluble PKC~ was co- 
incubated  with  1%  TX100- 
insoluble protein in the pres- 
ence  of  either  the  inactive 
phorbol  ester,  1  IxM  4ot- 
PDBu  (lanes  I  and 3),  or 1 
txM  413-PDBu (lanes  2  and 
4).  Insoluble  proteins  were 
then sedimented and the ab- 
sence of bound PKCa and 
was  confirmed  by  immuno- 
blot analysis of the unwashed 
pellets (data not shown). The 
phosphotransferase  reaction 
was  initiated  by  adding 
[~32p]ATP in the absence (lanes 3 and 4) or presence (lanes I and 
2) of 1 ixM PDBu. Insoluble pellets were washed three times to 
remove PDBu (lanes 3 and 4). PKCe-dependent phosphotrans- 
ferase activity was estimated by measuring changes in the phos- 
phorylation of an unidentified PKC substrate, having a molecular 
size of 80 kD. 
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the opportunity to directly test this hypothesis. Synaptoso- 
mal eytosolic and 1% TX100-insoluble fractions were co- 
incubated and the native PKC~ was induced to translocate 
to the insoluble fraction by adding 1 I~M 413-PDBu, in the 
absence of ATP, to the incubation medium. Insoluble pro- 
teins were then sedimented and either assayed directly or 
first washed three times to remove PDBu (Fig. 4, inset). 
Thus,  all  subsequent  413-PDBu-induced-phosphotrans- 
ferase  activity  in  the  washed  TX100-insoluble  fraction 
could be attributed to the insoluble form of PKCe. PKCe- 
dependent phosphotransferase activity was examined, in 
the presence of 0.1 mM EGTA, by measuring the autora- 
diographic densitometric intensity of an endogenous 80- 
kD  phosphoprotein  (p80;  Fig.  5).  Consistent  with  our 
working hypothesis, it was observed that the selective tar- 
geting of PKC~ to the TX100-insoluble fraction was asso- 
ciated with increased catalytic activity (Fig. 5, lanes I  and 
2).  Moreover, this increase in PKCe phosphotransferase 
activity was maintained (Fig. 5, lanes 3 and 4) after remov- 
ing >90% of the bound [3H]413-PDBu (Fig. 4, inset). 
4fl-PDBu Stimulates PKCe Translocation, 
PKCe-dependent  Phosphorylation, and Glutamate 
Exocytosis with Equivalent Potency 
Unless the 413-PDBu-induced translocation and activation 
of PKC~ are independent events, 413-PDBu should stimu- 
late both responses with equal potency. In vitro cosedi- 
mentation and phosphorylation assays were performed in 
the presence of increasing concentrations of 413-PDBu to 
compare the ECs0 values for these potentially interdepen- 
dent responses. The data were analyzed using the equa- 
tion: V =  (Vmax ×  [s]n)/(ECns0 +  [S]n); where V was PKCe 
binding,  phosphorylation  or  glutamate  exocytosis,  Vma  x 
was the maximal V, n was the Hill coefficient, [S] was the 
413-PDBu concentration employed, and ECs0 was the 4[3- 
PDBu concentration required to achieve Vmax/2. Estimates 
of the ECs0 values for the 413-PDBu-dependent transloca- 
tion of PKC~ in situ  (ECs0  =  193  nM)  and the in vitro 
PKC~-dependent  phosphorylation  of p80  (ECs0  =  402 
nM) did not markedly differ. Moreover, the ECs0 values 
for these responses were found to be nearly equivalent to 
that which was calculated from the results of our earlier 
release experiments (ECs0 =  159 nM; Tertian, 1995).  Re- 
gression analysis revealed a high degree of correlation be- 
tween the amount of PKCe bound and both the PKCe- 
dependent phosphorylation of p80 (r  2 =  0.737) and Ca  2+- 
dependent release of glutamate (r  2 =  0.988). These data 
provide circumstantial evidence that the 413-PDBu-induced 
translocation and activation of PKC~ are interdependent 
events that may represent a necessary prelude to the en- 
hancement of glutamate exocytosis. 
Conditions which Prevent the Interaction of  PKCe 
with the Presynaptic Cytoskeletal Matrix Prevent the 
4fl-PDBu-dependent Enhancement of 
Glutamate Exocytosis 
Two independent methods for preventing the 413-PDBu- 
dependent  enhancement  of  glutamate  exocytosis  have 
been established  (Tertian and Ways,  1995).  These treat- 
ments  were  used  to  perform  a  preliminary  analysis  of 
whether the cytoskeletal localization of PKCe was essen- 
tial for the 413-PDBu-dependent enhancement of glutamate 
exocytosis.  First,  intact  synaptosomes  were  pretreated 
with the PKC inhibitors, sphingosine and staurosporine, 
before the introduction of either 4a-PDBu or 4[3-PDBu. 
Synaptosomal suspensions were then used to conduct re- 
lease and translocation assays in parallel. The presence of 
inhibitors was maintained throughout all phases of the re- 
lease assay, since it has been shown previously that contin- 
uous inhibition was required to fully prevent the enhance- 
ment of glutamate release (Terrian and Ways, 1995). The 
ability  of this  treatment  to  completely abolish  the  413- 
PDBu-dependent  facilitation  of  glutamate  release  was 
confirmed in this experiment (Fig. 6 A). In agreement with 
predictions that the recruitment of PKCe to the cytoskele- 
tal matrix was required for the enhancement of glutamate 
release, sphingosine and staurosporine also blocked the in 
situ translocation of PKC~ (Fig. 6 A). In a second series of 
experiments, intact synaptosomes were incubated with cy- 
tochalasin D before the addition of PDBu. This treatment 
has  been  shown  to  completely  abolish  the  413-PDBu- 
dependent enhancement of glutamate exocytosis (Terrian 
and Ways, 1995).  Here, it is reported that cytochalasin D 
also prevented the in situ accumulation of insoluble PKCe 
(Fig. 6 B). 
4fl-PDBu-dependent Interactions of  PKCE with Actin 
The above observations suggest that ionic protein-protein 
interactions mediate the  binding of PKC¢ to either fila- 
mentous actin itself or to the actin-based skeletal frame- 
work  of isolated  nerve  endings.  To  determine  whether 
PKCe was anchored in the cytoskeletal matrix by either di- 
rect, or indirect, interactions with actin, we used recombi- 
nant gelsolin  (GS1-406),  a  highly specific actin  filament 
severing protein (Sun et al.,  1994).  Based on the known 
properties of GS1-406, it could be predicted that GS1-406 
activity would substantially decrease the average size of 
actin filaments in synaptosomal TX100-insoluble fractions 
and, thereby, solubilize proteins that were anchored to this 
aggregate by the insoluble form of filamentous actin. A 
portion  of  the  1%  TX100-insoluble  fraction  was  pre- 
treated with GS1-406 and the in vitro binding of PKC¢ was 
stimulated by 4[3-PDBu. GS1-406 decreased the amount of 
insoluble 13-actin (data not shown) and PKC~ (Fig. 7 A), 
providing  independent  confirmation  of  the  results  ob- 
tained using cytochalasin D in situ (Fig. 6 B). Overlay as- 
says were next performed in our attempt to identify the 
PKC¢-binding protein(s). These assays revealed that the 
synaptosomal  1%  TX100-insoluble  fraction contained  a 
43-kD  protein  that,  after  denaturation,  was  capable  of 
binding the native PKC¢ in vitro. Interestingly, the mobil- 
ity of this protein on SDS-PAGE gels precisely matched 
that  of the  endogenous  13-actin that  was  present  in  the 
same TX100-insoluble fraction (Fig. 7 B). The simplest in- 
terpretation of this finding was that PKC~ binds directly to 
actin. To test this hypothesis, in vitro cosedimentation as- 
says were  performed using  synaptosomal cytosolic frac- 
tions  and  purified filamentous actin.  The data  reported 
that native PKC~ was capable of binding to purified actin 
filaments,  under  physiological ionic strength  conditions, 
and that this binding was both saturable and significantly 
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hibitors  and  cytochalasin  D 
on the in situ translocation  of 
PKC~ and glutamate exocy- 
tosis.  (A)  Effect  of  stauro- 
sporine  and  sphingosine  on 
glutamate release and PKC~ 
translocation.  Intact synapto- 
somes were incubated in the 
absence or presence of stau- 
rosporine (1 t~M) and sphin- 
gosine  (100 o,M) for 20 min 
before the introduction  of 1 
I~M 4o~-PDBu or  413-PDBu. 
After  an  additional  10  min 
incubation,  aliquots from the 
same  synaptosomal  suspen- 
sion  were  used  to  perform 
parallel  supeffusion  and 
translocation assays. (B) Ef- 
fect  of  cytochalasin  D  on 
PKCe  translocation.  Intact 
synaptosomes  were  incu- 
bated in the absence or pres- 
ence  of  cytochalasin  D  (1 
~M) for 20 min before the in- 
troduction of 1 tzM 4et-PDBu 
or  413-PDBu. Translocation 
assays were performed after 
an additional  10-min incuba- 
tion. 
enhanced by the active isoform of PDBu (Fig. 7 C). Nei- 
ther PKCet nor PKC~ were detected by immunoblot analy- 
sis of these same actin pellets (data not shown). Although 
413-PDBu did not alter the affinity of native PKC~ for fila- 
mentous  actin,  the  Vm~x was  increased  almost  fourfold 
(Fig.  7  C).  ATP  was  required  to  obtain  consistent,  413- 
PDBu-dependent,  binding  of PKCe  and  Zn  2+  enhanced 
this effect (data not shown).  At a  fixed concentration  of 
purified  actin  (1  tzM)  and  cytosolic PKCe  (41  nM),  4[3- 
PDBu proved to be a potent stimulus for the in vitro asso- 
ciation of these native-binding partners (Fig. 7 D; EC50 = 
212 nM). 
Identification of  a Putative Actin-binding Motif 
in PKCe 
Sequence  motifs that  function  as  recognition  signals  for 
protein-protein interactions  have previously been identi- 
fied in competition experiments by coincubating the bind- 
ing proteins with synthetic peptides that are homologous 
to the putative binding sites. A  series of such experiments 
indicated  that none  of the  known PKC-binding domains 
were directly involved in actin binding. Indeed, neither the 
pseudosubstrate  peptide,  PKCa19.31  (10-55  }xM) nor  an- 
nexin I338.345 (5--20 ~M) had any effect on the in vitro bind- 
ing of native PKCe to actin in the absence or presence of 1 
p~M 4[3-PDBu (data not shown). However, analysis of the 
PKC¢ sequence revealed the presence of a motif that had 
previously been identified as a putative actin-binding mo- 
tif in several other actin-binding proteins (Fig. 8 A; Van- 
compernolle et al.,  1991).  While  this  actin-binding  motif 
was found to be conserved in the human, mouse, rat, and 
rabbit PKC~, it was not present in any other known iso- 
form of PKC, suggesting a mechanism that could account 
for the  selective redistribution  of cellular PKC~.  There- 
fore, we examined the  ability of a  synthetic hexapeptide 
that corresponded to the putative actin-binding domain of 
PKC~,  PKCe 223-228 (Fig.  8  A),  to  compete  with  native 
PKC~ for binding to purified actin and, in a  separate ex- 
periment,  1%  TX100-insoluble  synaptosomal  fractions. 
Consistent with the involvement of PKC~ 223-228 in the rec- 
ognition and binding of actin, this hexapeptide (LKKQET) 
competed, in a dose-dependent manner, with native PKC¢ 
for binding to either substrate (Fig. 8 B). Thus, PKCe con- 
tains a unique, actin-binding motif that appears to play an 
important part in the binding of this isoform to actin. 
What are the structural  determinants for actin binding 
to PKCe? The fact that PKCe-actin interactions were stim- 
ulated  by 4[3-PDBu  indicated  that  the  actin-binding  do- 
mains in PKCe may normally be hidden when this protein 
is in an inactive conformation. These contact sites for actin 
could be integrated into the secondary structure of native 
PKCe or consist of linear sequences that are complemen- 
tary  to  actin  (Vandekerckhove  and  Vancompernolle, 
1992). To better understand the requirements for the for- 
mation of this complex, equimolar concentrations of dena- 
tured,  and  presumably unfolded,  recombinant  PKCot,  ~, 
and e were individually tested for their ability to bind puri- 
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Figure 7. Identification of a cytoskeletal 
PKCe-binding protein. (A) Effect of re- 
combinant gelsolin  on the in vitro bind- 
ing of PKCe to native TX100-insoluble 
components.  TX100-insoluble  fractions 
were incubated with recombinant gelso- 
lin (GSI-406) for 1 h, at a protein ratio 
of 1:5, before  reintroducing  the  native 
cytosol.  Cosedimentation  assays  were 
used to measure changes in PKCe bind- 
ing.  (B)  Synaptosomal particulate  frac- 
tions were extracted with 1% TX100 and 
the insoluble fraction was separated on 
SDS-PAGE gels, transferred onto nitro- 
cellulose  membranes,  and  overlayed 
with the native cytosolic fraction. Mem- 
branes were then washed and cut in half 
before probing for either PKCe or 13-actin. 
(C) Cytosolic fractio!aS, containing ~350 
ng of native PKCe .(50 ixg cytosol), were 
incubated.with purified actin in the ab- 
sence  o~pres~nce  of 1  ~M  413-PDBu. 
PKC~ I~nding to actin was visualized  by 
immun~blot analysis. Curve fitting of the 
resultin~  values  was  performed  using 
Sigma Plot Scientific Graphing Software 
2.0 (Jandel Scientific Inc.). (D) Cytosolic 
fractions (t00 I~g) were coincubated with 
purified  actin  (10  Ixg) in  the  absence 
(control) or  presence  of  the  specified 
concentration of 41~-PDBu. PKCe bind- 
ing to actin was visualized  by immunoblot analysis. Data are the means of the values from three independent experiments. Curve fitting 
of the resulting values was performed using Sigma Plot Scientific Graphing Software 2.0 (Jandel Scientific Inc.). 
fled  actin.  Significant  binding  of purified  actin  to  PKC~ 
was observed at  a  physiological ionic strength  and in the 
absence of PDBu (Fig. 8  C). Actin binding to PKCa or 8 
was not detected  (data not shown), suggesting that PKC~ 
selectively  interacted  with  actin  under  these  conditions. 
The  ability of the  synthetic peptide,  LKKQET, to effec- 
tively compete with recombinant  PKC~ for actin binding 
(Fig. 8  C) provided independent support for our previous 
observations in which cytosol had been used as an alterna- 
tive source  of PKCe  (Fig.  8  B).  These  findings indicated 
that actin was a  PKCe binding protein  and that  small se- 
quence motifs in the primary structure of PKCe could con- 
tain  the  information that  was required  for actin recogni- 
tion and binding. 
AA and Diacylglycerol Synergistically Interact to 
Promote the Binding of PKCe to Actin Filaments 
While phorbol esters have greatly facilitated investigations 
into the presynaptic role  of PKCe, physiological agonists 
will  ultimately  be  required  for  evaluating  the  potential 
functional significance of our observations. The triggering 
events  that  expose  the  putative  actin-binding  domain  in 
PKC¢ in vivo are not known. However, the diacylglycerol 
and AA that are liberated from membrane phospholipids 
are  widely  regarded  as  putative  endogenous  signals  for 
PKC activation (Nishizuka,  1992).  To determine  whether 
these putative endogenous activators of PKC stimulate the 
binding of PKC¢ to purified  actin,  actin cosedimentation 
assays were performed using AA as the PKC activator, in 
the  presence  and  absence  of  the  diacylglycerol  analog, 
OAG (1 ixM). The data were analyzed using the equation: 
W  =  (Vma  x X  [s]n)/(ECn50  +  [s]n);  where  V  was  PKCe 
binding,  Vma  x was the  maximal  V, n  was the  Hill  coeffi- 
cient,  [S] was the AA concentration employed, and ECs0 
was the AA concentration required to achieve Vmax/2. Fig. 
9 indicates that AA was a potent stimulus for the binding 
of PKCe to actin (ECs0  =  10.9  ~M). The potency of AA 
was substantially increased (ECs0 =  0.6 IxM) when OAG, 
was added to the incubation medium (Fig. 9). 
Discussion 
We have identified a binding site for filamentous actin on 
PKC¢  that  is  unique  to  this  individual  isoform of PKC. 
This  actin-binding  site  was located between  the  first and 
second cysteine-rich regions (cysl and cys2) of the regula- 
tory C1 domain of PKC~, residues 223-228 (Fig. 8 A), in a 
variety of different species. Although it remains to be de- 
termined whether other PKC isoforms have also conserved 
such  unique  binding  motifs,  the  existence  of PKC,223.22  s 
makes it clear that a  mechanism has been established  for 
the pairing of individual PKC isoforms with specific intra- 
cellular PKC-binding proteins. This complexity in the con- 
trol of PKC targeting raises the question of what role these 
isoform-specific pathways  may play  in  the  regulation  of 
cell function.  In the case of PKCe, the remarkably stable 
interaction between PKCe223-228 and filamentous actin an- 
chors this kinase to the cytoskeletal matrix of presynaptic 
terminals,  where  the  holoenzyme  remains  constitutively 
active and appears to play a primary role in sustaining the 
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Figure 9. Effect of AA and OAG on PKCe binding to purified ac- 
tin. Actin-binding assays were performed as described in Materi- 
als and Methods by coincubating polymerized actin (100 p~g) and 
native PKCe (50 I~g cytosol) in the absence or presence of OAG 
(1 I~M) and in the presence of increasing concentrations of AA. 
Curve fitting was performed on the mean of two (AA alone) or 
three (AA with OAG) independent  determinations, using Sigma 
Plot Scientific Graphing Software 2.0 (Jandel Scientific, Inc.). 
Figure 8.  A synthetic peptide  that is homologous to PKC~223.228 
competes with PKC~ for actin binding. (A) Sequence and loca- 
tion of the putative actin-binding domain in PKC~ and compari- 
son with the homologous motif in other known actin-binding pro- 
teins. (B) Effect of PKCe223-228 (LKKQET) on the in vitro binding 
of native PKCe to purified actin and detergent-insoluble synapto- 
somal components.  Polymerized  actin (100 I~g) or 1% TX100- 
insoluble fractions (100 Ixg)  were preincubated with 50 p.g of syn- 
aptosomal cytosol (~ 350 ng of native PKCe), 1 p.M 413-PDBu, 
and the specified concentration  of PKCe223_228. for 30 min before 
cosedimenting filamentous actin and insoluble PKCe. The effi- 
cacy of 413-PDBu was confirmed in parallel controls that were si- 
multaneously incubated, without PKCe223-22s,  in the presence of 1 
IxM 4a-PDBu or 413-PDBu (see inset). (C) Actin binding to re- 
combinant, denatured,  PKCe measured by cosedimentation. Hu- 
man recombinant PKCe (i00 ng) was preincubated with purified 
actin (5 ~M) in the absence (lane 2) or presence (lane 3) of the 
synthetic hexapeptide, LKKQET (80 p.M). Lane 1 was a control 
that  contained  only  polymerized  actin. Actin  pellets were 
washed, fractionated by SDS-PAGE, and visualized by immuno- 
blotting with anti-PKCe. The same results were obtained in two 
independent experiments. 
slow phase of glutamate exocytosis. While a surplus of ma- 
ture synaptic vesicles are typically docked and primed for 
fusion, the supply of these vesicles must be actively replen- 
ished during bouts of high frequency stimulation (Lim et 
al., 1990). Many details regarding the mechanism that con- 
trois membrane recycling and the recruitment of fresh syn- 
aptic vesicles remain obscure. A step towards understand- 
ing how this mechanism operates is  the identification of 
PKCe as  one of the signaling molecules in this complex 
pathway. 
Do other members of the PKC family also participate in 
the recruitment of endogenous glutamate and long lasting 
facilitation  of exocytosis? This possibility cannot be for- 
mally  excluded  without  further  investigation.  However, 
the present study provides several observations of direct 
significance.  Endogenous PKCot,  13H, %  8,  e,  and  ~ were 
contained  in  the  hippocampal  P3  subcellular  fraction. 
However, the results of our colchicine lesion experiments 
indicated that only PKCe~, e, and ~ were localized to the 
hippocampal mossy fiber nerve endings in this synaptoso- 
mal preparation. This finding was consistent with electron 
microscopic observations that PKCe immunoreactivity is 
located in the hippocampal mossy fiber terminals (Saito et 
al., 1993), while both PKC13n and ",/appear to be excluded 
from  hippocampal  nerve  endings  (Kose  et  al.,  1990). 
PKCa is principally associated with the Golgi complex of 
hippocampal neurons (Ito et al., 1990) and little PKC~ im- 
munoreactivity is evident in this brain region (Merchen- 
thaler  et  al.,  1993).  Although PKC~  appeared  to  be  an 
abundant PKC isoform of mossy fiber origin, translocation 
assays confirmed that this enzyme does not respond to 413- 
PDBu.  413-PDBu  stimulated  the  in  situ  translocation  of 
PKCet, 13II, and ~/. However, the association of these PKC 
isoforms with the particulate fraction was reversed by ei- 
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(PKCet). PKCe was the only endogenous isoform of PKC 
to maintain a chelator-resistant interaction with an intra- 
cellular protein that could not be dissociated by removing 
413-PDBu.  These properties distinguished  PKC~  binding 
from either the Ca2÷-induced membrane binding, or mem- 
brane  insertion,  of PKC  (Bazzi  and  Nelsestuen,  1988). 
Thus,  multiple  isoforms  of PKC  may contribute  to  the 
transient effects of 413-PDBu on synaptic function, but the 
long lasting presynaptic effects of 413-PDBu  appeared to 
be mediated  by an isoform-specific pathway.  In  this  re- 
gard, it is of interest that the transfection-induced overex- 
pression of PKCe, but not other PKC isoforms, dramati- 
cally increases the  secretory activity of pituitary GHaC1 
cells (Akita et al., 1994). 
Actin filaments are a principal target for activated PKC~ 
in presynaptic terminals. This conclusion is supported by 
four independent lines of evidence. First, activated PKC~ 
remained  soluble  when  intact  synaptosomes  were  pre- 
treated with cytochalasin D  and when an aggregate of na- 
tive, detergent-insoluble, synaptosomal proteins were pre- 
treated with recombinant gelsolin. Second, overlay assays 
demonstrated that activated PKC~, but not other isoforms, 
bound  to  a  detergent-insoluble protein that  comigrated 
with 13-actin on SDS-PAGE gels. Third, both native and 
purified PKC~ bound directly to purified actin. Using cyto- 
solic PKC~, it was demonstrated that in the absence of PS 
this binding was  dose dependent, saturable, and specific 
for the PKCe isoform. Fourth, the binding of either native 
or recombinant PKCe to purified actin was effectively in- 
hibited by a synthetic hexapeptide with the sequence of a 
putative actin-binding domain that is present in the con- 
served C1 region of PKC~, PKC~223.228. Neither PKCct19_31 
nor  annexin  1338.345,  synthetic  peptides  that  have  been 
shown to compete for the binding of other PKC isoforms 
to anchoring proteins, had any effect on the interaction be- 
tween PKC~ and actin. PKC~ is the only member of the 
PKC  family to  have  preserved this  actin-binding  motif, 
which is also known to be present in a variety of other ac- 
tin-binding proteins (Vancompernolle et al.,  1991).  Thus, 
while the principle features of the  C1  region have been 
conserved in both the conventional and novel PKC iso- 
forms, individual isoforms may contain variable sequence 
motifs of functional significance. 
The properties of actin binding to PKC~ show that actin 
filaments represent a  new class  of PKC-binding protein 
that has not been revealed by earlier studies. Depending 
on what cell and PKC activator is used, the various iso- 
forms of PKC will preferentially bind to different intracel- 
lular sites within the nucleus (Disatnik et al.,  1994), peri- 
nuclear  region  (Staudinger  et  al.,  1995),  Golgi network 
(Lehel et al., 1995), plasma membrane (Bazzi and Nelses- 
tuen, 1988), and cytoskeleton (Wolf and Sahyoun, 1986). 
Even  phorbol  esters,  which  fully  activate  most  of  the 
known PKCs, redistribute the endogenous PKC isoforms 
of a given cell to different subcellular domains. This indi- 
cates that PKC-binding proteins are the principal determi- 
nants of targeting specificity, since activated PKC can only 
associate with those microdomains that are capable of rec- 
ognizing and binding these enzymes (Mochly-Rosen, 1995). 
In contrast to the RACKs (Mochly-Rosen et al., 1991; Ron 
et al.,  1994) and other PKC-binding proteins (Chapline et 
al.,  1993; Liao et al.,  1994) that have been identified, fila- 
mentous actin bound directly to activated PKCe, in the ab- 
sence of PS. Actin is also clearly distinguished from the re- 
cently described PICK proteins (Staudinger et al.,  1995) 
by the fact that PICKs interact with the catalytic domain 
of PKC, whereas actin seems to bind the regulatory do- 
main of PKC~. An in vitro study has indicated that PKCI3 
and ~/may also be capable of interacting with actin, in a 
PS-dependent manner (Zalewski et al.,  1991).  However, 
many PKC isoforms that interact with lipid vesicles and 
purified proteins in in vitro systems do not associate with 
these receptors in the intact cell (Szallasi et al., 1994). Our 
assays of PKC binding have demonstrated that PKCe was 
the only endogenous isoform of PKC that directly inter- 
acted with purified actin in the absence of PS. Moreover, it 
has been shown that PKCe tightly binds to actin filaments 
in the intact nerve terminal. Thus, actin appears to be a 
novel PKC-binding protein that displays distinct and iso- 
form-specific requirements for physiological binding. 
Actin binding stimulates a persistent increase in consti- 
tutive PKC~ activity. The discovery that the insoluble form 
of PKC~ could be isolated from all other endogenous iso- 
forms of PKC provided an opportunity to examine the ef- 
fect of actin binding on the Ca2÷-independent activity of 
this novel PKC isoform. It is concluded that neither pro- 
teolytic activation nor irreversible insertion can account 
for the increased PKCe activity that was observed in the 
present study. Proteolytic cleavage of PKC~ produces an 
effector-independent increase  in  phosphotransferase  ac- 
tivity (Schaap et al.,  1990).  While the carboxyl terminal 
catalytic fragment of PKCE that is  generated by limited 
proteolysis has been shown to bind nonneuronal interme- 
diate  filaments, it does not bind to actin  (Omary et al., 
1992).  As actin filaments were the principal binding pro- 
tein for PKC~ in the synaptosomal preparation, this cata- 
lytic fragment would not be expected to cosediment with 
the  washed  detergent-insoluble  aggregate  to  which  the 
full-length PKCe was  bound.  Moreover, it may be  con- 
cluded that the constitutive activation of PKCe did not re- 
sult from hydrophobic interactions of this kinase with a 
lipid bilayer. This would be consistent with the observa- 
tions that bound PKCe could not be solubilized by high 
concentrations of either TX100 or octyl glucoside and that 
the in vitro PKCe binding and phosphotransferase activity 
were unaffected by phospholipids,  such  as  PS.  Whether 
autophosphorylation was responsible for the persistent ac- 
tivation of PKC~ is unknown. The available evidence indi- 
cates that the activity of PKCe may be influenced by an in- 
tramolecular  or  intermolecular  form  of  kinase  activity 
(Koide  et  al.,  1992;  Saido  et  al.,  1992).  Studies  are  in 
progress to determine whether dephosphorylation alters 
the  constitutive  phosphotransferase  activity  of  actin- 
bound PKC~. However, the simplest possibility is that acti- 
vators  of  PKC~  simultaneously  produce  an  allosteric 
activation of the enzyme and expose a cryptic binding se- 
quence for actin filaments  (Fig.  10).  This implies that  a 
transient increase in PKCe activity could be maintained, in 
the  absence  of stimulatory  cofactors  and  indifferent to 
changes in PKC~ phosphorylation, for several hours by the 
ability of actin filaments to tightly bind and activate PKCe. 
The model in Fig. 10 provides a basis for our findings and 
identifies a  PKCe binding and activating protein, whose 
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Figure 10. Model for the as- 
sembly and constitutive  acti- 
vation of a PKCe-specific sig- 
naling complex. Binding of an 
activator, such as arachidonic 
acid/diacylglycerol, would be 
required  to  simultaneously 
promote the allosteric activa- 
tion of PKC~ and to expose a 
cryptic binding  site  for  the 
cytoskeletal  protein,  actin 
(step  1).  The  anchoring  of 
PKCe to actin  (step 2)  does 
not require, but is associated 
with,  increased  phospho- 
transferase activity. Metabo- 
lism of the endogenous acti- 
vator for PKCe would result 
in the reversal of some actin 
binding  and the resolubiliza- 
tion of inactive PKC¢ (step 3). However, a pool of the PKC¢ that remains tightly bound to actin continues to be catalytically active in 
the absence of the agonist that initially targeted this PKC isoform into the cytoskeletal matrix (step 4). Reversible and stable binding of 
PKC¢ to this protein may be preferentially induced by partial and complete agonists, respectively. This model suggests that actin repre- 
sents a bifunctional, chaperone and anchoring protein that is specific for the PKC¢ isoform. The assembly and stabilization of this actin- 
PKC~ complex appears to play a primary role in the PKC-dependent  enhancement of sustained glutamate exocytosis (step 5). 
existence  was  first  suggested  by  Parker  and  colleagues 
(Pears et al., 1991). Such a mechanism would assign an ad- 
ditional  level  of  functional  significance  to  bifunctional 
PKC-anchoring proteins that  are capable of maintaining 
PKCs in a catalytically active conformation. 
PKCe binding to purified actin was synergistically stimu- 
lated  by AA  and  the  diacylglycerol analog,  OAG.  The 
presence of PKCe in the TX100-insoluble fraction of freshly 
isolated synaptosomes indicated that the enzyme had been 
physiologically activated in these terminals. Candidate sig- 
nals for PKCe activation included AA and diacylglycerol, 
because these two lipid metabolites had previously been 
shown  to  increase  PKCe-dependent  phosphotransferase 
activity (Koide et al., 1992; Kasahara and Kikkawa, 1995) 
and the evoked release of endogenous glutamate (Zhang 
and Dorman, 1993).  The present results are in agreement 
with the hypothesis that AA is a potent endogenous acti- 
vator of PKC~, while PS effectively activates PKCa, 13, % 
and 8, but not PKCe (Kasahara and Kikkawa, 1995).  In the 
absence of either Ca  2÷ or PS, AA significantly increased 
the binding of PKCe to filamentous actin. Although OAG 
by itself had no effect on the binding of actin by PKCe, the 
addition of OAG when AA was present caused a synergis- 
tic enhancement  of PKCe binding.  A  similar interaction 
results in the potentiation of glutamate release from syn- 
aptosomal  preparations  (Zhang  and  Dorman,  1993).  In 
this  preparation,  the  stimulation  of  metabotropic  glu- 
tamate receptors effectively mimics the permissive effect 
of OAG on  AA-induced  release  (Herrero  et  al.,  1992). 
Thus, phospholipid metabolism may well participate in the 
physiological  activation  of  PKCe  and  this  mechanism 
seems to be closely regulated. Optimal activation appears 
to be contingent upon the coactivation of presynaptic me- 
tabotropic glutamate receptors, for the production of dia- 
cylglycerol and phospholipase A2, for the liberation of AA 
(Nishizuka,  1992).  Both conditions  are likely to be satis- 
fied during the bouts of intense presynaptic activity that 
produce a long lasting increase in neurotransmitter release 
(Schulz et al., 1994). 
Formal and direct proof that a causal relationship exists 
between the actin binding of PKC~, the constitutive activa- 
tion of this kinase, and the enhancement of glutamate re- 
lease will require further investigation. However, it is pos- 
sible to estimate the  likelihood that these response data 
sets represent interdependent  events by comparing their 
individual ECs0 values for 4[3-PDBu. As the ratio of these 
ECs0 values approach unity there  is  a  corresponding in- 
crease  in  the  confidence  that  such  a  relationship  exists. 
The result of such an analysis estimated that there is a rea- 
sonably high (>95%) probability that the translocation of 
PKCe,  PKCe binding  to  actin,  and  the  enhancement  of 
glutamate exocytosis were functionally related. These re- 
sults,  together  with  the  demonstration  that  treatments 
which  prevent PKCe binding  and activation also abolish 
the enhancement of glutamate release by 4[3-PDBu, are in 
agreement with  the  suggestion  that  the  extent  to which 
phorbol esters facilitate the slow phase of glutamate exo- 
cytosis may be influenced by the binding of PKCe to actin. 
The present results suggest that the individual isoforms 
of PKC may have assumed distinct responsibilities for the 
control  of regulated  secretion.  In the  case of PKC~, we 
have  discovered  that  this  specificity  could  have  been 
achieved through the conservation of an actin-binding mo- 
tif in this, but not in other PKC isoforms. The existence of 
this distinct binding site in PKC~ explains how this isoform 
becomes specifically paired with, and tightly bound to, ac- 
tin filaments in the presynaptic cytoskeletal matrix. Use- 
dependent changes in lipid metabolism have been shown 
to be capable of generating  the  endogenous signals that 
are  required  to  expose  this  actin-binding  site  in  native 
PKCe. Once bound to actin, PKCe remained constitutively 
active in  the  absence  of lipid  metabolites  or  membrane 
phospholipids. Thus, actin not only appears to be a novel 
and specific PKC~-binding protein, but may also act as an 
Prekeris et al. Function of  an Actin-binding Site Unique to the PKCE Isoform  89 agonist that is capable of maintaining this kinase in a cata- 
lytically active conformation for several hours (Fig.  10). 
The  assembly  of this  isoform-specific signaling  complex 
may have multiple and diverse influences on synaptic func- 
tion. The present results, together with our previous stud- 
ies, indicate that one outcome of functional significance 
may be the enhanced availability of synaptic vesicles for 
exocytosis during intense bouts of presynaptic activity. 
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